Most PI marketing directors have had the conversation where case management complains about lead quality. “The cases from this aggregator are soft tissue only.” “Half the people we signed from that TV campaign had pre-existing conditions.” “The Google leads are converting but they're all low-value.”
These observations may be accurate. But they are impressions, not measurements. Without a system that connects case quality data back to the originating lead source, you cannot verify them, you cannot quantify them, and you cannot act on them in a way that changes your marketing spend.
This post explains how to build that connection — so that case quality stops being a complaint and starts being a data point that drives vendor decisions.
Define “Case Quality” Before You Measure It
Case quality means different things at different firms. Before building a tracking system, you need a working definition that is measurable, consistent, and relevant to the types of cases your firm handles.
For most PI firms, case quality can be approximated with three variables:
- Case severity tier: A categorical assessment of the injury type and projected complexity — soft tissue, moderate (treatment without surgery), significant (surgery or hospitalization), severe or catastrophic. The exact tiers should match how your attorneys naturally evaluate cases.
- Projected case value: An estimate of expected fees or settlement range at the time of signing. This can be rough — a range rather than a precise number — but it needs to exist as a structured data field, not a case note.
- Case progression rate: Whether the case is progressing normally through your pipeline stages, or whether it has stalled, been reduced in scope, or flagged for early closure.
You do not need all three immediately. Case severity tier is the easiest to capture and the most useful starting point. Even a rough three-tier system (minor, moderate, significant) tracked at signing gives you something to analyze by lead source.
The Attribution Chain: From Lead Source to Case Outcome
Connecting case quality back to a lead source requires an unbroken attribution chain through four systems:
1. Lead Entry and Source Tagging
When a lead arrives — whether through a web form, a live transfer, a phone call, or a referral — it needs to be tagged with a source identifier that persists throughout the case lifecycle. This tag should be specific: not just “aggregator” but the specific vendor, campaign, or referral source. Phone leads should be tracked via dedicated numbers by source. Web leads should carry UTM parameters or vendor-specific landing page identifiers.
2. Intake and Case Signing
When a lead becomes a signed case, the source tag from the lead record must carry over to the case record. This is the most common breakpoint in the attribution chain. Firms using separate platforms for lead intake and case management — for example, LeadDocket for intake and Filevine for case management — often find that the handoff between platforms drops the source tag. RevenueScale's integration layer is designed to preserve this source tag across every system handoff — this is one of the core problems it solves.
3. Case Quality Assessment
When the case is opened in case management, the attorney or paralegal who does the initial case review should populate the severity tier and projected value fields as part of the case opening workflow. If these fields are optional, they will be inconsistently populated. They need to be required fields with a defined taxonomy.
4. Reporting and Analysis
The case quality fields need to be accessible in a reporting layer that also has the source tag. This is where you close the loop — pulling a report that shows average case severity, projected case value, and case progression rate by lead source for a defined signing cohort.
What the Data Reveals
Once you have 90–180 days of case quality data attributed by source, a few patterns typically emerge that were invisible before.
Source-Level Severity Concentration
Some lead sources will show a heavy concentration in the lowest severity tier — soft tissue, minor impact cases. Others will show a healthier distribution across severity levels. If a vendor is sending you 80% minor cases and your portfolio average is 55% minor, that vendor is pulling your average case value down. On a $60K monthly contract, you may be buying a dramatically lower-value case mix than your blended metrics suggest.
Value-Adjusted Cost Per Case
Standard cost per signed case treats all signed cases as equivalent. Once you have projected case value by source, you can calculate a value-adjusted cost per case — essentially, cost per expected dollar of revenue. This metric exposes situations where a “cheap” source on a cost-per-lead or cost-per-case basis is actually expensive when adjusted for the value of the cases it produces.
For example: Vendor A has a cost per signed case of $900. Average projected case value is $18,000. Cost per $1,000 of projected value: $50. Vendor B has a cost per signed case of $1,400. Average projected case value is $45,000. Cost per $1,000 of projected value: $31. Vendor B is cheaper on a value-adjusted basis despite being 55% more expensive per signed case.
| Metric | Vendor A | Vendor B | |
|---|---|---|---|
| Cost Per Signed Case | $900 | $1,400 | |
| Avg Projected Case Value | $18,000 | $45,000 | |
| Cost Per $1K of Value | $50 | $31 | |
| Value-Adjusted Winner? | No | Yes |
Case Stall Rate by Source
Tracking which sources produce cases that stall in early pipeline stages — pre-demand cases that haven't progressed to medical treatment or haven't submitted records after 60 days — is a leading indicator of case quality problems. Cases stall for many reasons, but a disproportionate stall rate from one source often indicates that signed clients from that source are less engaged or less cooperative than clients from other sources. This is another withdrawal precursor that can be caught earlier.
How to Have the Vendor Conversation With This Data
Once you have case quality data by source, the vendor conversation changes in a specific way. You are no longer arguing about lead quality in the abstract. You are presenting a comparison.
A productive vendor conversation with this data looks something like: “We've been tracking case severity across our vendor portfolio for the last six months. Our portfolio average for minor cases is 52%. For your leads that became signed cases in that period, the minor case rate was 74%. That is a significant divergence. We'd like to understand what is driving it in your targeting, and what you can do to shift the mix.”
This is a fundamentally different conversation than “your leads have been lower quality.” It is specific, it is documented, and it gives the vendor something concrete to respond to. A good vendor will investigate and adjust. A vendor who cannot explain or address the divergence is telling you something important about the relationship.
How Long Before the Data Is Reliable
Case quality attribution takes time to produce reliable signals. The reasons are practical: you need enough signed cases from each source to draw statistically meaningful conclusions, and the case quality assessment happens at signing — so you need a full cycle of lead entry, intake, and case opening before the data starts accumulating.
For most PI firms running multi-vendor portfolios, 60–90 days of consistent data capture produces enough volume to see patterns for high-volume sources. For lower-volume sources — referrals, specialty campaigns, social media — you may need 4–6 months.
The answer is not to wait before starting. The answer is to start capturing the data now and set a calendar reminder to review it at 90 days. You will not have complete information at 90 days, but you will have directional information — enough to ask better questions and identify which sources warrant deeper investigation.
Connecting Case Quality Back to Marketing Budget
The ultimate purpose of connecting case quality to lead source is not reporting — it is budget allocation. A marketing director who can show that one vendor produces cases with 2.5x the average projected value at only 1.4x the cost per signed case has a clear, defensible argument for budget reallocation.
That argument cannot be made from cost per lead. It cannot be made from conversion rate. It can only be made from case quality data attributed back to the source — and that data is available in your firm right now, waiting to be captured and connected. RevenueScale's case analytics makes this attribution automatic once your integrations are live.
Related guide: See our complete guide to lead source tracking for law firms — the 4-level attribution chain, 8 data points, and 5-step tracking system every PI firm needs.
Related guide: See our complete guide to PI lead generation by case type — how marketing economics change by practice area, with CPC benchmarks and channel strategies for each case type.
Related guide: See our complete guide to PI intake performance — the 8 metrics every PI firm should track, benchmarks, and how to connect intake data to marketing attribution.